CDKI-IN-1
CDKI-IN-1 (Compound SNX12) is a cyclin-dependent kinase inhibitor (CDKI) inhibitor that can be used for research into degenerative diseases of the central nervous system[1].
Product Specifications
CAS Number
[1185726-51-5]
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Neurological Disease
Smiles
C=CCN1C2=C(C=CC=C2)N=C1/C=C/C3=CC=CO3.Cl
Molecular Formula
C16H15ClN2O
Molecular Weight
286.76
References & Citations
[1]Bey-Dih Chang, et al. Cdki pathway inhibitors and uses thereof. Patent, US20090281129. 2009-11-12.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6223853-01 0.1 mL
PIN1 (Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1, Peptidyl-prolyl Cis-trans Isomerase Pin1, PPIase Pin1, Rotamase Pin1) (MaxLight 650)
Ask
View Details 
MBS6223853-02 5x 0.1 mL
PIN1 (Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1, Peptidyl-prolyl Cis-trans Isomerase Pin1, PPIase Pin1, Rotamase Pin1) (MaxLight 650)
Ask
View Details MBS6223637-01 0.1 mL
PAK3 (Serine/Threonine-protein Kinase PAK 3, Beta-PAK, Oligophrenin-3, p21-activated Kinase 3, PAK-3, OPHN3) (MaxLight 650)
Ask
View Details MBS6223637-02 5x 0.1 mL
PAK3 (Serine/Threonine-protein Kinase PAK 3, Beta-PAK, Oligophrenin-3, p21-activated Kinase 3, PAK-3, OPHN3) (MaxLight 650)
Ask
View Details